ELSEVIER
Regulatory Peptides 59 (1995) 410-412
Contents of volume 59 Number 1, 22 September 1995 Instructions to Authors
Review Biological actions of galanin J.N. Crawley (USA)
Regular Papers Combined non-radioactive detection of peptide hormones and their mRNAs in stomach somatostatin cells S. Bo/kent, S. Yilmazer and M. Ozturk (Turkey)
17
Mapping of cyclosporin A binding sites in cyclophilin A by using synthetic peptides K. Yamamoto, N. Kurokawa, M. Kadobayashi, N. Tauchi, K. /guchi, N. Yanaihara and C. Yanaihara (Japan)
23
Molecular forms of rat angiotensinogen in plasma and brain: identification by isoelectric focusing and immunoblot analysis W.G. Thomas, D. Kerr and C. Semia (Australia)
31
Neuroendocrine peptides stimulate adenyl cyclase in normal and malignant prostate cells P.J. Gkonos, B.L. Lokeshwar, W. Balkan and B.A. Roos (USA)
43
Substance P gene expression in acute experimental colitis M. Reinshagen, G. Adler and V.E. Eysse/ein (Germany, USA)
53
Melanocortins and opioids modulate early postnatal growth in rats A. Mauri, M.R. Me/is, P. Deiana, A. Loviselli, A. Volpe and A. Argiolas (Italy)
59
Endocrine cells with gastrinlcholecystokinin-like immunoreactivity in the pancreas of the spiny dogfish, Squalus acanthias A.-C. JOnsson (Sweden)
67
Cerebrospinal fluid ~endorphin in models of hyperalgesia in the rat F.W. Bach, S.R. Chap/an, J. Jang and T.L. Yaksh (USA, Denmark)
79
The in vitro and in vivo resistance of synthetic enkephalin analogs to three enkephalin-hydrolyzing enzymes K. Ghoda, K. Iwao, X.-F. Liu, T. Taniguchi and 7". Oka (Japan)
87
The effect of body weight on the calcitonin gene-related peptide-induced relaxation of guinea pig gallbladder strips L.W. Kline and P.K. 7". Pang (Canada)
97
Mechanisms of proton-induced stimulation of CGRP release from rat antrum J. Ren, Y. Wang, K. Liang, J. Gao, K. Brewer and R.F. /-/arty (USA)
103
~-Fluoromethylhistidine influences somatostatin content, binding and inhibition of adenylyl cyclase activity in the rat frontoparietal cortex L. Puebla and E. Arflla (Spain)
111
Pituitary adenylate cyclase activating polypeptide is expressed in autonomic neurons H. Mulder, R. Uddman, K. Moiler, T. Elshs, E. Ekblad, J. Alumets and F. Sundler (Sweden, Norway)
121
Announcements
129
0167-0115/95/$09.50 © 1995 Elsevier Science B.V. All fights reserved
Contents of volume 59
411
Number 2, 20 October 1995 Editorial Review In vivo applications of antisense oligonucleotides for peptide research M./. Phi/lips and R. Gyurko (USA) Regular Papers Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain S. Ogawa, H.E. Brovm, H.J. Okano and D.W. Pfaff (USA) In vivo antisense approa,ches to the role of immediate early gene expression in the brain C. Cirelli, M. Pompei~no and G. Tononi (USA, Italy) Antisense oligonucleotide inhibition of tryptophan hydroxylase activity in mouse brain M.M. McCarthy, D.A. Nielsen and D. Goldman (USA) A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin AT1 receptor P. Amb~hl, R. Gyurko and M.I. Phillips (USA) Intracerebroventricular administration of angiotensin type 1 (AT1) receptor antisense oligonucleotides attenuate thirst in the rat R.R. Sakai, L.Y. Ma, P.F. He and S.J. Fluharty (USA) Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventdcular and intrahippocampal administration determined by in situ hybridization Y. Yaida and T.S. Nowak, Jr. (USA) Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding M. Heilig (Sweden) ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release M.G. Hulsey, C.M. PIess, B.D. White and R.J. Martin (USA) Central administration of antisense oligodeoxynucleotides to neuropeptide Y (NPY) mRNA reveals the critical role of newly synthesized NPY in regulation of LHRH release P.S. Kalra, J.J. Bonavera and S.P. Kalra (USA) Expression of antisense PC1 in stably transfected RIN5F cells significantly reduces CCK 8 biosynthesis J. Y. Yoon and M.C. ~geinfeld (USA) Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats G. Liebsch, R. Landgraf, R. Gerstberger, J.C. Probst, C.T. Wotjak, M. Engelmann, F. Holsboer and A. Montkowski (Germany) ICV administration of arti-corticotropin-releasing factor antisense oligonucleotide: effects on feeding behavior and body weight M.G. Hulsey, C.M. PIess and R.J. Martin (USA) Opioid peptide receptor :3tudies. 4. Antisense oligodeoxynucleotide to the delta opioid receptor delineates opioid receptor subtypes X. Y. Cha, H. Xu, Q. Ni, J.S. Partilla, K.C. Rice, D. Matecka, S.N. Calderon, F. Porreca, J. Lai and R.B. Rothman (USA) Antisense oligodeoxynucleotide to a 8-opioid receptor blocks the antinociception induced by cold water swimming H. Mizoguchi, M. Nafita, H. Nagase and L.F. Tseng (USA, Japan) Oxytocin antisense reduces salt intake in the baroreceptor-denervated rat M. Morris, P. LL C. Barrett and M.F. Callahan (USA) Announcements
iii
131
143 151 163
171
183
193
201
207
215 221
229
241
247 255 261 267
412
Contents of volume 59
Number 3, 10 November 1995
Review Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions J.W. Wright and J. W. Harding (USA)
269
Regular Papers Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice B. Ahr~n, R.L. Gingerich and P.J. Have/(Sweden, USA)
297
Binding of valsartan to mammalian angiotensin AT1 receptors M. De Gasparo and S. Whitebread (Switzerland)
303
Pericardial repair depresses canine cardiac catacholamines and met-enkephalin B.A. Barton, C.E. Jones and J.L. Caffrey (USA)
313
VIP antagonist demonstrates differences in VIP- and PHI-mediated stimulation and inhibition of ACTH and corticosterone secretion in rats L.D. Alexander and L.D. Sander (USA)
321
Opposite changes in the content of oxytocin- and vasopressin-like immunoreactive peptides in the rat thymus during aging M.R. Me~is, A. Maud and A. Argio/as (Italy)
335
Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells K. Kask, M. Berthold, J. Bourne, S. Andell, O. Langel and T. Bartfai (Sweden)
341
Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis V. Dupouy and J.-M. Zajac (France)
349
Bronchodilating effects of natriuretic and vasorelaxant peptides compared to salbutamol in asthmatics T. FlOge, H. Fabel, T.O.F. Wagner, B. Schneider and W.G. Forssmann (Germany)
357
Initiating and responsible enzyme of arginine v.asopressin degradation in human placenta and pregnancy serum S. Mizutani, M.A. Safwat, K. Goto, M. Tsujimoto, H. Nakazato, A. Itakura, M. Mizuno, O. KurauchL F. Kikkawa and Y. Tomoda (Japan)
371
Expression of angiotensin I-converting enzyme in the human gastric HGT-1 cell line I. Nonotte, M.-F. Lalibert~, N. R&my-Heintz, Fo Lalibert~ and C. Chevillard (France)
379
Neurochemical markers of human fungiform papillae and taste buds J. Astb~ck, K. Arvidson and O. Johansson (Sweden)
389
Announcements
399
Author index
401
Keyword index
405
Contents of volume 59
410